These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23845221)

  • 1. Development of 3D-QSAR CoMSIA models for 5-(biphenyl-2-yl)-1H-tetrazole derivatives as angiotensin II receptor type 1 (AT1) antagonists.
    Choi MJ; Kwon GH; Han NS; Yoo BW; Kim JH; Paik SH; Chi YH; Lee KT; Lee JY
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4540-6. PubMed ID: 23845221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
    Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
    Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
    Vyas VK; Ghate M; Chintha C; Patel P
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fimasartan, a novel angiotensin II receptor antagonist.
    Kim JH; Lee JH; Paik SH; Kim JH; Chi YH
    Arch Pharm Res; 2012 Jul; 35(7):1123-6. PubMed ID: 22864732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Krovat EM; Langer T
    J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural elucidation of impurities in 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichlorophenyl)-3H-1,2,4-triazol-3-one (Ib), a novel nonpeptide angiotensin AT1 receptor antagonist.
    Gao T; Liu Y; Ji Y; Wu X; Xu J
    J Pharm Biomed Anal; 2012 Jul; 66():381-6. PubMed ID: 22516679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
    J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
    Vaidya M; Weigt M; Wiese M
    Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
    Sharma MC
    Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3.
    Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.